Abstract
Aim: To evaluate an appropriate planning target volume (PTV) margin in for one to three vertebral metastases using megavolt computed tomography (MVCT) images during the course of image-guided and stereotactic intensity-modulated radiotherapy (IGRT-IMRT) by use of helical tomotherapy. Patients and Methods: A total of 25 lesions in 24 patients with vertebral metastases who received IGRT-IMRT were analyzed. MVCT images were acquired before and after radiation therapy. Intra-fractional movement and PTV margin were calculated by comparing treatment planning images and these 310 MVCT images for right-left (RL), superior-inferior (SI), and anteroposterior (AP) dimensions. Five patients were treated by 35 Gy/5 fractions, 17 by 30 Gy/5 fractions, one by 25 Gy/5 fractions, and one by 60 Gy/30 fractions. A margin to compensate for these variations was calculated with the formula of vanHerk's equation. Results: The intra-fractional motion was 0.02 (−1.3 to 1.4) ± 0.34 mm in the RL direction, −0.09 (−1.8 to 0.28) ± 0.44 mm in the SI direction, and 0.20 (−1.8 to 1.8) ± 0.36 mm in the AP direction. The required PTV margin was 0.98 mm in the RL direction, 0.69 mm in the SI direction, and 1.26 mm in the AP direction. No patient showed a deviation greater than 2 mm. Conclusion: The PTV margin in hypofractionated IGRT–IMRT, using helical tomotherapy for a few vertebral metastases, was 2 mm or less and our tentative PTV margin of 5 mm was sufficient and reducible.
Radiation therapy is a common and effective treatment modality for managing skeletal metastases. The possible irradiated dose to vertebral metastases is limited for tumors located near the spinal cord when conventional external beam techniques are used. Recent advances in technology have improved the therapeutic threshold, permitting delivery of an ablative radiation dose using an image-guided stereotactic approach (1). In addition, in the era of modern radiotherapy techniques, the planned target volume (PTV) to vertebral metastases can be reduced by precise positioning, i.e. by image-guided and stereotactic intensity-modulated radiotherapy (IGRT–IMRT) (2). Because helical tomotherapy has the ability to acquire megavoltage computed tomographic (MVCT) images of a patient in the treatment position before each treatment, daily imaging can minimize daily positional uncertainties (2). This precise positioning allows the PTV to be reduced, directly improving conformal avoidance of nearby critical structures. Therefore, we initiated an assessment of the required PTV margin in IGRT–IMRT for a few vertebral metastases using helical tomotherapy.
Patients and Methods
We evaluated 25 lesions in 24 patients with one to three vertebral metastases who received IGRT–IMRT using helical tomotherapy (HI-ART TomoTherapy Inc., Madison, WI, USA) between December 2007 and February 2009. Patient characteristic are shown in Table I. One patient was treated for cervical and lumber spine twice. Vacuum cushions (Blue Bag, Medical Intelligence, Schwabműenchen, Germany) were used to immobilize the patients in a supine position. Custom Aquaplast masks (WFR Aquaplast, Inc., Avondale, PA, USA) were also used to immobilize the patients with cervical spine targets.
Kilovoltage CT images were acquired for each patient (2-mm slice thickness) at least 5 cm above and below the level of PTV. The spinal cord was defined as an organ at risk. The gross tumor volume was contoured; the vertebral body was contoured as a clinical target volume (CTV), which was expanded into the PTV by adding a uniform 5-mm margin around the CTV and subtracting the cord volume at risk. The dose was set as D95: 95% of the PTV was to receive the prescribed dose. Five patients were treated by 35 Gy/5 fractions, 17 by 30 Gy/5 fractions, one by 25 Gy/5 fractions, and one by 60 Gy/30 fractions. The maximum dose to the spinal cord was set with the highest inverse priority so that the total cord dose did not exceed 50 Gy (BED2Gy=n × d × (α/β + d)/(α/β + 2), where BED=biological equivalent dose, n=number of fractions, d=fraction dose, and α/β=2). The patients were then positioned for each delivery fraction on the HI-ART table and aligned using wall-mounted lasers.
MVCT using 3.5-MV energy images were acquired through PTV before treatment delivery with the minimum slice thickness (4 mm) and field of view (35 cm). The first MVCT images were taken and autofused with the kV CT treatment planning images, and the superior–inferior (SI), anterior–posterior (AP), and right–left (RL) shifts were calculated by automatic image fusion and then manually verified and corrected by two of the authors (rotational corrections were not implemented at the time of this study). The patients were then shifted along calculated couch translations. For the initial 12 lesions of 11 patients, MVCT (second MCVT) images were acquired to verify that the shifts were correctly applied. The images were manually inspected by two of the authors, and the patients were then re-adjusted (if necessary) and treated. The third MVCT image was taken to assess intrafractional organ motion after radiation therapy. The total time between image acquisition and treatment delivery was typically less than 10 min. Intrafractional movement was calculated by comparing the second and third MVCT images. The second MVCT images were omitted because little displacement (<1 mm) was found between the second MVCT image and the expected location by the shifts applied. Thereafter, the first and third MVCT images were used to calculate intrafractional organ motion in the subsequent 13 lesions in 13 patients. Intrafractional movement was calculated by comparing the expected location by the shifts applied to the first and third MVCT image locations. vanHerk's formula (2.5Σ + 0.7σ, where Σ and σ were systematic and random positioning errors, respectively) was used to calculate the PTV margin to compensate for these variations (3).
Results
Five patients were treated with 35 Gy/5 fractions, 17 by 30 Gy/5 fractions, one by 25 Gy/5 fractions, and one by 60 Gy/30 fractions. In each patient, five fractions were examined by repeated MVCT, and the 310 MVCT images were analyzed for deviations. Intrafractional motion was 0.02 mm (−1.3 to 1.4 mm) ± 0.34 mm in the RL direction (right direction regarded as positive), −0.09 mm (−1.8 mm to 0.28 mm) ± 0.44 mm in the SI direction (superior direction regarded as positive), 0.20 mm (−1.8 mm to 1.8 mm) ± 0.36 mm in the AP direction (anterior direction regarded as positive). In detail, the intrafractional motions in the RL, SI, and AP directions for the cervical spine were 0.3 mm ± 0.38 mm, −0.05 mm ± 0.37 mm, and −044 mm ± 0.56 mm, respectively; for the thoracic spine, 0.02 mm ± 0.30 mm, −0.17 mm ± 0.47 mm, and 0.24 mm ± 0.40 mm, respectively; and for the lumber spine, −0.17 mm ± 0.23 mm, 0.14 mm ± 0.34 mm, and 0.25 mm ± 0.23 mm, respectively. No patient showed a deviation greater than 2 mm (Figure 1). Therefore, the required PTV margin was 0.98 mm in the RL direction, 0.69 mm in the SI direction, and 1.26 mm in the AP direction. All patients were treated without any adverse effects.
Discussion
In contrast to the relatively disappointing outcomes reported with conventional fractionation or low-dose single-fraction radiotherapy, high-dose single or fractionated radiation therapy was shown to be highly effective in the palliation of metastatic spinal cord tumors (4). Gerszten and Welch reported on 500 patients with paraspinal lesions treated with 12-25 Gy (maximal intratumoral dose) single-fraction radiation therapy (5). Stereotactic radiosurgery was the primary treatment modality for the spinal lesions in 65 patients. The control of symptoms was excellent; 86% of the patients reported decrease in pain and 90% were reported to have local control. Toxicity was minimal, including no treatment-related myelopathy. Similar favorable results have also been reported by several others (6-9). Following those results, we initiated IGRT–IMRT in patients with a few vertebral metastases.
Hyde et al. reported that the absolute intra-fractional motion averaged over all directions along the x, y, and z axes (SD) were 0.7±0.5 mm and 0.5±0.4 mm for the 1.5- and 1-mm tolerances, respectively. On the basis of a 1-mm and 1 correction threshold, the target was localized to within 1.2 mm and 0.9 mm, respectively, with 95% confidence using Cyberknife (10). These values are consistent with our results. Mahan et al. reported that anthropomorphic phantom studies indicated that MVCT images in tomotherapy were capable of imaging the spine with sufficient accuracy to place the isocenter within 1 mm of the desired position (2). Our results showed that the required maximal PTV margin was 1.26 mm in the AP direction. Therefore 2.26 mm margin (1.26 + 1 mm) for the PTV is enough to compensate for image ambiguity.
One of the limitations of this study was that we applied vanHerk's equation because it is a widely known formula for conventional multifractionation radiotherapy, although here it was used for hypofractionated stereotactic radiation therapy. Even so, no patient showed a deviation greater than 2 mm; thus, our tentative 5-mm PTV margin was sufficient for IGRT–IMRT for cases with few vertebral metastases.
In conclusion, the PTV margin in hypofractionated IGRT–IMRT using helical tomotherapy for a few vertebral metastases could be 2 mm or less. Our tentative PTV margin of 5 mm was sufficient and reducible, if required.
- Received March 12, 2013.
- Revision received May 2, 2013.
- Accepted May 8, 2013.
- Copyright© 2013 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved